LPCN Shares Outstanding History



Below is a table of the LPCN shares outstanding history going back to 7/25/2013:

Date LPCN Shares Outstanding
7/25/20132059
11/12/2013650375
3/21/2014751305
3/27/2014751305
5/12/2014751305
8/13/2014752157
11/10/2014752157
3/11/2015755792
5/7/20151.07M
8/10/20151.07M
11/11/20151.07M
3/9/20161.07M
5/9/20161.07M
8/9/20161.07M
11/8/20161.07M
3/3/20171.09M
5/5/20171.13M
8/4/20171.22M
11/8/20171.25M
3/9/20181.25M
5/4/20181.25M
8/6/20181.25M
11/5/20181.26M
3/4/20191.40M
5/6/20191.45M
8/5/20191.46M
11/11/20191.49M
3/12/20202.81M
5/6/20202.82M
8/4/20203.86M
11/9/20203.86M
3/9/20215.19M
5/5/20215.19M
8/4/20215.19M
11/9/20215.19M
3/7/20225.19M
5/6/20225.21M
8/3/20225.21M
11/7/20225.21M
8/8/20235.32M
3/5/20245.32M

Also see: LPCN Market Cap History
LPCN YTD Return
LPCN Historical Shares Outstanding:
+109.55% CAGR
LPCN Historical Shares Outstanding: +109.55% CAGR

Mouse over chart for data details
7/25/2013 ...3/5/2024
Lipocine is clinical-stage biopharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products focusing on neuroendocrine and metabolic disorders. Co. has a license agreement for the development and commercialization its product candidate, TLANDO®, an oral testosterone replacement therapy comprised of testosterone undecanoate. Co.'s additional pipeline candidates, LPCN 1148 comprising a prodrug of testosterone, testosterone laurate, for the management of decompensated cirrhosis. Co. is conducting a Phase 2 POC study in male cirrhotic subjects to evaluate the therapeutic potential of LPCN 1148 for the management of sarcopenia. We show 41 historical shares outstanding datapoints in our coverage of LPCN's shares outstanding history.

Understanding the changing numbers of LPCN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LPCN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LPCN by allowing them to research LPCN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree LPCN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Lipocine (LPCN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

LPNT Shares Outstanding History
LPTX Shares Outstanding History
LQDA Shares Outstanding History
LRMR Shares Outstanding History
LSTA Shares Outstanding History
LTRN Shares Outstanding History
LUCD Shares Outstanding History
LUMO Shares Outstanding History
LUNG Shares Outstanding History
LVGO Shares Outstanding History
More Healthcare companies »

 

LPCN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.